Tempest Therapeutics Inc (TPST) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TPST Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Tempest Therapeutics Inc manages its resources, obligations, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent1.81
Cash & Short-term Investments1.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.64
Total Current Assets2.45
Equipment/Property/Plant Net0.55
Other Assets, Noncurrent7.76
Operating Lease Right Of Use Asset7.25
Total Assets10.75
Liabilities
Accounts Payable, Current AC0.59
Accrued Liabilities, Current1.49
Long-term Debt, Current Maturities LO0.00
Total Current Liabilities3.31
Total Long-term Debt0.00
Other liabilities, Noncurrent7.85
Operating Lease Liability Current1.24
Operating Lease Liability Noncurrent6.62
Total Liabilities9.93
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock270.88
Retained Earnings / Accumulated Deficit-270.07
Other Equity0.00
Common Stockholder's Equity0.82
Total Stockholder's Equity0.82
Liabilities & Stockholder's Equity10.75
4 historic quarters locked

Sign in to unlock the full Tempest Therapeutics Inc balance sheet history.

About Tempest Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-349381

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.